Q4 2013 13F Holders as of 12/31/2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
50.9M
-
Number of holders
-
192
-
Total shares
-
54.7M
-
Shares change
-
-305K
-
Total reported value, excl. options
-
$2.3B
-
Value change
-
-$12.3M
-
Number of buys
-
1
-
Number of sells
-
-6
-
Price
-
$42.13
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q4 2013
193 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q4 2013.
HAEMONETICS CORP - Common Stock (HAE) has 192 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.7M shares
.
Largest 10 shareholders include Neuberger Berman Group LLC (5.72M shares), VANGUARD GROUP INC (3.4M shares), BlackRock Fund Advisors (2.84M shares), TimesSquare Capital Management, LLC (2.52M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (2.06M shares), Capital World Investors (2.06M shares), PRUDENTIAL PLC (1.89M shares), BlackRock Institutional Trust Company, N.A. (1.37M shares), SNYDER CAPITAL MANAGEMENT L P (1.29M shares), and Champlain Investment Partners, LLC (1.29M shares).
This table shows the top 192 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.